What S The Outlook For Viridian Therapeutics Vrdn Stock This Year Price At 18.84 Down 1.62 20260402 The opportunity most miss about Amdocs DOX 088 20260511 GD Culture GDC Stock Is It Trending or Ranging GD Culture posts zero revenue and 016 per share net loss FVCB FVCBankcorp shares rise nearly 1 percent as 146 percent year over year Q4 2025 revenue growth offsets a small EPS miss The quality metrics hidden in Global Net GNLD earnings GNLD Q3 Earnings Global Net Series D Declares Quarterly Dividend Generative AI Sector Criminal Liability Probe Regulatory and Market Implications LECO Q1 2026 Earnings Narrow EPS Beat Underscores Operational Discipline GAIA Q1 2026 Earnings EPS Misses Estimates Amidst Transition Stock Rises 5 Aurora Innovation Q1 2026 Earnings EPS Beat Masks PreRevenue Reality Amid Ongoing Development Costs SNAP Q1 2026 Earnings EPS Slightly Exceeds Estimates Stock Edges Higher MCW Q1 2026 Earnings EPS Surges Past Estimates with 1444 Beat Stock Holds Steady Ramaco Resources Q1 2026 Earnings Coal Producer Misses EPS Estimates Shares Rise TLK Q4 2025 Earnings EPS Misses Estimations Significantly Stock Declines 472 OKUR Q1 2026 Earnings WiderThanExpected Loss Reflects ClinicalStage Investment COGT Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline Absci Corporation Q1 2026 Earnings Surprise EPS Beat Amid No Revenue Disclosure MacroGenics MGNX Q1 2026 Earnings Narrowing Loss on EPS Surprise as Stock Rebounds AVAL Q2 2025 Earnings Strong EPS Report Amid Mixed Macro Signals